MEDICA Newsletter
Social Media
More about…
- 3D printing and additive manufacturing
- Adiposity
- Age
- Alzheimer's
- Antibiotics
- Artificial intelligence
- Biocompatible
- Biomarker
- Biotechnology
- Blood
- Brain
- Brain Tumour
- Breast
- CT
- Cancer
- Cardiovascular diseases
- Care
- Cells
- Communication
- Dementia
- Depression
- Devices
- Diabetes
- Diagnostics
- Disinfection
- Drugs
- EEG
- EU
- Environment
- Epilepsy
- Eyes
- Financing
- Fitness
- Genetic material
- Genetics
- Germany
- Global health
- Gynecology
- Healthcare politics
- Heart
- Hospital
- Hospital information system
- Hygiene
- Imaging
- Immune system
- Implants
- Infectious diseases
- Information technology
- Intestine
- Kidney
- Knee
- Laboratory
- Laser
- Liver
- Lung
- MEDICA 2022
- MRI
- Mammography
- Materials
- Media
- Medical apps
- Medical market
- Microtechnology
- Minimally invasive
- Multiple Sclerosis
- Nanotechnology
- Neurology
- Nuclear medicine
- Nutrition
- Optical technologies
- Optimisation
- Organs
- Orthopedics
- Pain
- Pathogens
- Pathology
- Patients
- Personalized Medicine
- Physiotherapy
- Pregnancy
- Prevention
- Prosthesis
- Psychology
- Radiology
- Regenerative Medicine
- Rehabilitation
- Research
- Risks
- Robotics
- SARS-CoV-2/COVID-19
- Safety
- Screening
- Screening
- Senses
- Skin
- Sleep
- Smart textiles
- Software
- Sports medicine
- Stem cells
- Sterilisation
- Stroke
- Surgery
- Surgical intervention
- Telemedicine
- Therapy
- Tissue engineering
- Transplantation
- Treatment
- Ultrasound
- Vaccination
- Virtual Reality and Augmented Reality
- Wearable technologies
- Women
- Wound care and wound healing
- X-ray devices
- mHealth
Karin Kaiser / MHH, Freepik.com
MHH leads EU large-scale project for personalized cancer care
26/01/2023
CAN.HEAL aims to expand the available innovations in cancer prevention, diagnosis and treatment in the Member States in order to improve care for all patients in the EU. The project focuses on measures of personalized medicine. Genomics is an important cornerstone for this.
gstockstudio
New blood test differentiates neurodegeneration in Alzheimer’s disease from other dementias
23/01/2023
A new blood test that can track and follow the neurodegeneration in Alzheimer’s disease – and exclude other dementias.
National University of Singapore
Scientists identify blood biomarker for cognitive impairment and dementia
02/01/2023
A recent study by a team comprising researchers from the National University of Singapore (NUS) and the National University Health System (NUHS) revealed that low levels of ergothioneine (ET) in blood plasma may predict an increased risk of cognitive impairment and dementia, suggesting possible therapeutic or early screening measures for cognitive impairment and dementia in the elderly.
University of the Basque Country
Micrometric blood plasma separator using high-resolution 3D fabrication
16/12/2022
Researchers at the UPV/EHU-University of the Basque Country have developed a microfluidic plasma separator to optically detect blood biomarkers.
westend61
Ground-breaking new method for multi-cancer early detection
16/12/2022
An international study led by researchers from Chalmers University of Technology, Sweden, shows that a new, previously untested method can easily find multiple types of newly formed cancers at the same time – including cancer types that are difficult to detect with comparable methods.
gstockstudio
Optimal blood tests for development of new therapies of Alzheimer’s disease
14/12/2022
A new study has identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression.
NUS Institute for Health Innovation & Technology
New cancer testing method makes regular monitoring affordable
09/12/2022
Scientists from the National University of Singapore (NUS) have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, this new test sequences clinical samples that have been heated in order to isolate cancer-specific signatures found in a patient’s blood.
Karin Kaiser / MHH
Fighting depression with personalised medicine
01/12/2022
Under the leadership of Professor Dr Helge Frieling, Vice Head of the Department of Psychiatry, Social Psychiatry and Psychotherapy at the Hannover Medical School (MHH), a national research network is now being launched that aims to tailor the treatment of depression more closely to the individual patient than before.
prostooleh
New troponin test improves heart attack diagnostics
07/11/2022
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency.
imagesourcecurated
Newly identified biomarkers could revolutionize heart failure diagnosis
04/11/2022
Researchers at the University of Oslo have identified specific groups of biomarkers that could differentiate between types of heart failure. The possible future benefit for patients is the identification of type of heart failure trough a simple blood test.
Fraunhofer IZM/ Technische Universität Berlin
Sensor bracelet measures environmental forces, improves treatment of lung diseases
03/11/2022
Tiny particulates or noxious gases: From the day they are born, all people are exposed to a range of environmental forces. These forces constitute the exposome and affect the health and wellbeing of people around the world. A European research project has been set up to explore how the exposome affects the course of lung diseases.
mahirkart
Rare cancers: early detection of hereditary cancer risk
31/10/2022
Hereditary genetic mutations play an important role in oncogenesis, but they usually remain undetected.
panthermedia.net/olanstock
Cardiac diagnostics – prompt and personalized
08/11/2019
If physicians suspect an acute myocardial infarction, they first order an ECG. This test is very established and allows cardiologists to quickly diagnose acute heart attacks – though the test does not detect less common heart attack symptoms. So far, those patients had to wait up to twelve hours before a heart attack could be accurately diagnosed or ruled out. But things are about the change.